Cargando…
Library of Selenocyanate and Diselenide Derivatives as In Vivo Antichagasic Compounds Targeting Trypanosoma cruzi Mitochondrion
Chagas disease is usually caused by tropical infection with the insect-transmitted protozoan Trypanosoma cruzi. Currently, Chagas disease is a major public health concern worldwide due to globalization, and there are no treatments neither vaccines because of the long-term nature of the disease and i...
Autores principales: | Martín-Escolano, Rubén, Molina-Carreño, Daniel, Plano, Daniel, Espuelas, Socorro, Rosales, María J., Moreno, Esther, Aydillo, Carlos, Sanmartín, Carmen, Sánchez-Moreno, Manuel, Marín, Clotilde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147293/ https://www.ncbi.nlm.nih.gov/pubmed/34062791 http://dx.doi.org/10.3390/ph14050419 |
Ejemplares similares
-
Selenium Derivatives as Promising Therapy for Chagas
Disease: In Vitro and In Vivo Studies
por: Martín-Escolano, Rubén, et al.
Publicado: (2021) -
Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments
por: Calvo-Martín, Gorka, et al.
Publicado: (2022) -
Unveiling a New Selenocyanate as a Multitarget Candidate with Anticancer, Antileishmanial and Antibacterial Potential
por: Ramos-Inza, Sandra, et al.
Publicado: (2022) -
Paired Electrolysis Enabled Cyanation of Diaryl Diselenides with KSCN Leading to Aryl Selenocyanates
por: He, Wei-Bao, et al.
Publicado: (2023) -
A structure-based approach towards the identification of novel antichagasic compounds: Trypanosoma cruzi carbonic anhydrase inhibitors
por: Llanos, Manuel A., et al.
Publicado: (2019)